Related search

Proteomics Markers Prognostic for Outcome of Chronic Lymphocytic Leukemia Patients Under Treatment: Results From the Hovon-109 Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Overview of Non-Coding Mutations in Chronic Lymphocytic Leukemia

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

MYD88 Mutations Predict Unfavorable Prognosis in Chronic Lymphocytic Leukemia Patients With Mutated IGHV Gene

Blood Cancer Journal
OncologyHematology
2017English

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

ISRN Oncology
2014English

A Quantitative Analysis of Subclonal and Clonal Gene Mutations Before and After Therapy in Chronic Lymphocytic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2016English

ATM and Chronic Lymphocytic Leukemia: Mutations, and Not Only Deletions, Matter

Haematologica
Hematology
2011English

Genetic Characterization of SF3B1 Mutations in Single Chronic Lymphocytic Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial

Haematologica
Hematology
2016English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy